Ghryvelin

macimorelin acetate · Atnahs Pharma Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ghryvelin, covering 2024-05-13 to 2024-05-13. Get the full timeline:

Most recent: EMA Authorised: Ghryvelin (previously Macimorelin Aeterna Zentaris) (macimorelin acetate) — Atnahs Pharma Netherlands B.V.